"One and a half x is the new 10x."

Kurt von Emster, partner with VenBio, during a panel at the 2011 BIO Investor Forum

"Instead of asking the FDA to lower the bar, just get drug developers that can jump higher."

Sanjay Shukla, CEO of RxMD, of the current regulatory environment

"You almost have to negotiate the divorce before you negotiate the marriage."

Michael Margolis, managing director with Roth Capital Partners, talking about ironing out all the details of a multiple-asset partnership

"I think if we're sitting here three or four years from now, we're not even using the terminology 'corporate venture' and 'traditional venture.'"

Brian McVeigh, vice president of worldwide business transactions and investment management at GlaxoSmithKline plc